Report: Off-Label Prescribing: Overcoming the Reimbursement Barrier TOC

Off-Label Prescribing: Overcoming the Reimbursement Barrier

Published by

Decision Resources, Inc.

Published

2006/06

Content info

25 Pages

Product code

DR41355

Price

From US $ 1112

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

Overview

United States

Scale of Off-Label Prescribing
- Antineoplastic Drugs
- Antidepressants
- Antipsychotics
- Anticonvulsants
Perils of Off-Label Marketing
Reimbursement
- Medicare
- Medicaid
- Private Insurers

France

Germany

Italy

United Kingdom

Japan

Outlook and Implications for the Pharmaceutical Industry

Related Report

Off-Label Prescribing: Overcoming the Reimbursement Barrier